193 related articles for article (PubMed ID: 29799517)
1. The ABP Dendrimer, a Drug-Candidate against Inflammatory Diseases That Triggers the Activation of Interleukin-10 Producing Immune Cells.
Fruchon S; Poupot R
Molecules; 2018 May; 23(6):. PubMed ID: 29799517
[TBL] [Abstract][Full Text] [Related]
2. Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4(+) T Cells.
Hayder M; Varilh M; Turrin CO; Saoudi A; Caminade AM; Poupot R; Liblau RS
Biomacromolecules; 2015 Nov; 16(11):3425-33. PubMed ID: 26397709
[TBL] [Abstract][Full Text] [Related]
3. An azabisphosphonate-capped poly(phosphorhydrazone) dendrimer for the treatment of endotoxin-induced uveitis.
Fruchon S; Caminade AM; Abadie C; Davignon JL; Combette JM; Turrin CO; Poupot R
Molecules; 2013 Aug; 18(8):9305-16. PubMed ID: 23921793
[TBL] [Abstract][Full Text] [Related]
4. Interaction studies reveal specific recognition of an anti-inflammatory polyphosphorhydrazone dendrimer by human monocytes.
Ledall J; Fruchon S; Garzoni M; Pavan GM; Caminade AM; Turrin CO; Blanzat M; Poupot R
Nanoscale; 2015 Nov; 7(42):17672-84. PubMed ID: 26335052
[TBL] [Abstract][Full Text] [Related]
5. Curing inflammatory diseases using phosphorous dendrimers.
Caminade AM; Turrin CO; Poupot R
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1783. PubMed ID: 35194953
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer.
Fruchon S; Poupot M; Martinet L; Turrin CO; Majoral JP; Fournié JJ; Caminade AM; Poupot R
J Leukoc Biol; 2009 Mar; 85(3):553-62. PubMed ID: 19047518
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution and Biosafety of a Poly(Phosphorhydrazone) Dendrimer, an Anti-Inflammatory Drug-Candidate.
Fruchon S; Bellard E; Beton N; Goursat C; Oukhrib A; Caminade AM; Blanzat M; Turrin CO; Golzio M; Poupot R
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31514434
[TBL] [Abstract][Full Text] [Related]
8. An Anti-Inflammatory Poly(PhosphorHydrazone) Dendrimer Capped with AzaBisPhosphonate Groups to Treat Psoriasis.
Jebbawi R; Oukhrib A; Clement E; Blanzat M; Turrin CO; Caminade AM; Lacoste E; Fruchon S; Poupot R
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32586038
[TBL] [Abstract][Full Text] [Related]
9. Oxysterols regulate encephalitogenic CD4(+) T cell trafficking during central nervous system autoimmunity.
Chalmin F; Rochemont V; Lippens C; Clottu A; Sailer AW; Merkler D; Hugues S; Pot C
J Autoimmun; 2015 Jan; 56():45-55. PubMed ID: 25456971
[TBL] [Abstract][Full Text] [Related]
10. Dendrimers to treat rheumatoid arthritis.
Bosch X
ACS Nano; 2011 Sep; 5(9):6779-85. PubMed ID: 21879710
[TBL] [Abstract][Full Text] [Related]
11. Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy.
Portevin D; Poupot M; Rolland O; Turrin CO; Fournié JJ; Majoral JP; Caminade AM; Poupot R
J Transl Med; 2009 Sep; 7():82. PubMed ID: 19778420
[TBL] [Abstract][Full Text] [Related]
12. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis.
Hayder M; Poupot M; Baron M; Nigon D; Turrin CO; Caminade AM; Majoral JP; Eisenberg RA; Fournié JJ; Cantagrel A; Poupot R; Davignon JL
Sci Transl Med; 2011 May; 3(81):81ra35. PubMed ID: 21543721
[TBL] [Abstract][Full Text] [Related]
13. An Immunomodulatory Peptide Dendrimer Inspired from Glatiramer Acetate.
Erzina D; Capecchi A; Javor S; Reymond JL
Angew Chem Int Ed Engl; 2021 Dec; 60(50):26403-26408. PubMed ID: 34618395
[TBL] [Abstract][Full Text] [Related]
14. Resistin Gene Expression is Downregulated in CD4(+) T Helper Lymphocytes and CD14(+) Monocytes in Rheumatoid Arthritis Responding to TNF-α Inhibition.
Nagaev I; Andersen M; Olesen MK; Nagaeva O; Wikberg J; Mincheva-Nilsson L; Andersen GN
Scand J Immunol; 2016 Oct; 84(4):229-36. PubMed ID: 27434862
[TBL] [Abstract][Full Text] [Related]
15. Repeated intravenous injections in non-human primates demonstrate preclinical safety of an anti-inflammatory phosphorus-based dendrimer.
Fruchon S; Mouriot S; Thiollier T; Grandin C; Caminade AM; Turrin CO; Contamin H; Poupot R
Nanotoxicology; 2015 May; 9(4):433-41. PubMed ID: 25051330
[TBL] [Abstract][Full Text] [Related]
16. Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent.
Degboé Y; Fruchon S; Baron M; Nigon D; Turrin CO; Caminade AM; Poupot R; Cantagrel A; Davignon JL
Arthritis Res Ther; 2014 Apr; 16(2):R98. PubMed ID: 24745366
[TBL] [Abstract][Full Text] [Related]
17. Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
Miyagaki T; Fujimoto M; Sato S
Int Immunol; 2015 Oct; 27(10):495-504. PubMed ID: 25957264
[TBL] [Abstract][Full Text] [Related]
18. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.
Milovanovic M; Volarevic V; Ljujic B; Radosavljevic G; Jovanovic I; Arsenijevic N; Lukic ML
PLoS One; 2012; 7(9):e45225. PubMed ID: 23028861
[TBL] [Abstract][Full Text] [Related]
19. Three-Dimensional Directionality Is a Pivotal Structural Feature for the Bioactivity of Azabisphosphonate-Capped Poly(PhosphorHydrazone) Nanodrug Dendrimers.
Hayder M; Garzoni M; Bochicchio D; Caminade AM; Couderc F; Ong-Meang V; Davignon JL; Turrin CO; Pavan GM; Poupot R
Biomacromolecules; 2018 Mar; 19(3):712-720. PubMed ID: 29443507
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of regulatory B10 cells in patients with rheumatoid arthritis with different disease status.
Zheng Z; Li X; Li X; Ding J; Feng Y; Miao J; Luo X; Wu Z; Zhu P
Mol Med Rep; 2015 Sep; 12(3):4584-4591. PubMed ID: 26081876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
